Partnership Opportunities in Drug Delivery (PODD) 2023 Pre-Conference Issue: An Interview with Jarlath Keating, CEO of Phosphorex

October 12, 2023

Jarlath Keating, CEO of Phosphorex, discusses strategies and approaches to optimize development and manufacturing of novel therapeutics.. .

Innovations to Facilitate New Therapeutics Development CEO of Phosphorex, Jarlath Keating, discusses strategies and approaches to optimize development and manufacturing of novel therapeutics, cross-industry collaboration and innovations that will enable
CLICK HERE FOR ARTICLE. 
Phosphorex can be found on pages 5-6.
Events